KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 92 filers reported holding KRYSTAL BIOTECH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,758,748 | +3.2% | 32,403 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $3,641,160 | +139998.5% | 31,015 | -4.5% | 0.00% | +33.3% |
| Q1 2023 | $2,599 | +3.1% | 32,469 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $2,522 | -99.9% | 31,834 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $2,169,000 | +16.0% | 31,123 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $1,870,000 | +17.9% | 28,485 | +19.5% | 0.00% | +50.0% |
| Q1 2022 | $1,586,000 | +4.6% | 23,839 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $1,516,000 | +34.8% | 21,667 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $1,125,000 | -20.0% | 21,544 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $1,407,000 | +21.7% | 20,684 | +37.9% | 0.00% | 0.0% |
| Q1 2021 | $1,156,000 | +27.5% | 14,999 | -0.7% | 0.00% | +100.0% |
| Q4 2020 | $907,000 | +54.0% | 15,110 | +10.5% | 0.00% | 0.0% |
| Q3 2020 | $589,000 | -6.4% | 13,675 | -10.0% | 0.00% | 0.0% |
| Q2 2020 | $629,000 | +19.6% | 15,195 | +24.8% | 0.00% | 0.0% |
| Q1 2020 | $526,000 | -16.0% | 12,175 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $626,000 | +75.4% | 11,308 | +10.1% | 0.00% | 0.0% |
| Q3 2019 | $357,000 | +2.3% | 10,270 | +18.6% | 0.00% | 0.0% |
| Q2 2019 | $349,000 | – | 8,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |